FDA Discovers Contaminated Products, Unsterile Conditions at Ameridose

The FDA has released a 20-page inspection report outlining subpar conditions at Ameridose, sister company of the New England Compounding Center in Framingham, Mass., according to a USA Today report.


Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

The report details a string of shortcomings, including ineffective drugs, unsterile or dilapidated environmental conditions and wildlife, at Ameridose. Sister company NECC is at the center of a federal investigation into a meningitis outbreak believed to be linked to contaminated NECC products. So far, the outbreak has claimed 32 lives and more than 400 meningitis illnesses.

Ameridose has already voluntarily recalled its products in late October after the FDA reported the company could not demonstrate product sterility and safety.

More Articles on Patient Safety:

Patient Safety Tool: IHI's JOINTS Hospital Registry Template

5 Ways to Increase Anesthesia Cost-Effectiveness in ASCs

4 Risk Factors for Immediate Use Sterilization

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Patient Safety Tools & Resources Database

Featured Webinars

Featured Whitepapers

Featured Podcast